An Analysis of Recent FDA Oncology Scientific Publications

In addition to its primary regulatory role, the Office of Hematology and Oncology Products at the U.S. Food and Drug Administration (FDA) is engaged in many forms of scientific authorship. During the period of 2010 to 2018, FDA oncology staff contributed to 356 publications in the scientific literat...

ver descrição completa

Na minha lista:
Detalhes bibliográficos
Publicado no:Oncologist
Main Authors: Schneider, Julie A., Miklos, Andrew C., Onken, James, Gong, Yutao, Calcagno, Anna Maria, Blumenthal, Gideon M., Aragon, Richard, Pazdur, Richard
Formato: Artigo
Idioma:Inglês
Publicado em: John Wiley & Sons, Inc. 2019
Assuntos:
Regulatory Issues: FDA
Acesso em linha:https://ncbi.nlm.nih.gov/pmc/articles/PMC7066718/
https://ncbi.nlm.nih.gov/pubmed/32162806
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1634/theoncologist.2019-0503
Tags: Adicionar Tag
Sem tags, seja o primeiro a adicionar uma tag!

Registos relacionados